Heights Capital Management’s Benitec Biopharma BNTC Stock Holding History
Bought
Maintained
Sold
Other funds holding BNTC
Heights Capital Management's BNTC Position: Q4 2022 in Review
Heights Capital Management sold out of Benitec Biopharma (BNTC) in Q4 2022, closing a stake of 75,831 shares — an estimated $479K sold.
Heights Capital Management first reported a position in BNTC in Q3 2022 and held it in 1 quarter. The position peaked at $479K in Q3 2022. 25 funds tracked by Wall St. Rank hold BNTC as of Q4 2022.
- Heights Capital Management reported no remaining Benitec Biopharma position as of Q4 2022 after selling out during the quarter.
- Heights Capital Management sold 75,831 Benitec Biopharma shares in Q4 2022, an estimated $479K.
- Heights Capital Management first reported a position in Benitec Biopharma in Q3 2022 and held it in 1 quarter.
- Heights Capital Management's Benitec Biopharma position peaked at $479K in Q3 2022.
- 25 funds tracked by Wall St. Rank held Benitec Biopharma as of Q4 2022.
Based on Heights Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.